However, other studies demonstrate that the expressions of chemerin are upregulated in grade III/IV glioma tissues and overexpression of chemerin in orals quamous cell carcinoma is correlated with poor clinical outcomes of patients [10, 11]. The gene discussed is RARRES2; the disease is glioma.